A few studies enrolling limited series of patients have performed serial ultrasound examinations after an acute episode of Applying the single criterion of full compressibility of the common femoral and popliteal veins, compression ultrasound (C-US), a complete normalization of the test has been demonstrated in a small number of patients after 6 to 12 months; therefore, these studies suggest that real-time C-US cannot be reused in a large proportion of patients with suspected DVT and has a limited value for the detection of recurrent DVT. 9 Recent reports suggest that the thrombus mass progressively decreases after the initial thrombotic episode.7,10 Furthermore, our experience in large series of patients with recurrent proximal DVT diagnosed with phlebography11,12 suggests that the apposition of fresh thrombotic material to the preexisting clot follows the anatomic distribution pattern observed in the first episode,13 involving the common femoral vein, the popliteal vein, or both. Therefore, the ultrasound quantification of thrombus regression in these two venous segments could help in recognizing patients with recurrent proximal DVT by providing the baseline reference with which to compare the new ultrasound findings at the time of referral for suspected recurrence.
We performed a two-step study. First, in a crosssectional survey, we rescanned 149 patients with proximal DVT with only the C-US method. Subsequently, we performed a prospective ultrasound investigation in 145 additional patients with proximal DVT. This second phase was designed to assess the reproducibility of a new technique for thrombus mass measurement and to test its utility for the diagnosis of recurrent DVT.
Methods
Step 1 To assess the frequency of normalized C-US test results in the follow-up of patients with acute proximal DVT, all consecutive outpatients were identified in whom a diagnosis of acute lower-extremity proximal DVT had been established with venography and C-US test between 1986 and 1988 at the Thrombosis Center of Padua University. All patients had been treated in the acute phase with full-dose heparin followed by at least 3 months of oral anticoagulants.1112
Patients were asked to return to the Thrombosis Center and received a single C-US test with knowledge of the original clot location with an ATL Ultramark 4 scanner with a 7.5 -MHz linear-array transducer. The method and criteria of diagnosis were defined previously. ' The decision to set up a cut-off level of 2 mm (± 1, no change; .2 mm, DVT recurrence) was taken a priori on the basis of the following considerations. Because of the resolution power of the ultrasound machine, an interobserver variability of ±1 mm in the measurement of thrombus thickness does indeed exist. It was assumed that, when DVT recurs in a proximal venous segment that still has residual thrombotic material in its lumen, it results in an enlargement of thrombus mass detectable by ultrasonography. Accepting an interobserver variability of ± 1 mm, the minimum cutoff level to prevent false-positive results is 3 mm; however, it would result in the possibility of missing thrombi as large as 4 mm. Consequently, the choice of 2 mm seemed the most adequate to identify clinically relevant thrombi, thus accepting the risk of false-positive results but reducing the hazard of missing potentially dangerous thrombi.
The only phlebographic criterion for diagnosing a recurrence of DVT was an intraluminal filling defect absent in the previous venography. In the case of an indeterminate venographic picture, diagnosis was adjudicated by means of a radiofibrinogen uptake test according to previously described criteria.4,15 Ultrasonographic, phlebographic, and radioisotopic findings were interpreted by independent and blind observers.
The study protocol was approved by the Institutional Review Board of Padua University. Analysis
In the cross-sectional survey (step 1), percentages of normalization and the relative 95% confidence intervals (CI) were calculated for any time by standard methods.
In the prospective phase (step 2), the cumulative The interobserver agreement in the ultrasound estimation of thrombus regression was calculated in a subset of 100 tests by having an independent evaluation by a second observer. The agreement rate between the two observers was assessed by K-function analysis.
The sensitivity and specificity (and the 95% CI) of the C-US method as well as of the combined ultrasound methods (C-US and thrombus thickness) for detection of recurrent proximal-vein thrombosis were calculated by standard methods.
Results Phase 1
Of the 178 patients identified, 12 had died, 11 had experienced recurrent DVT, and 6 did not agree to participate. Therefore, 149 patients were included in the study.
The median age of the study patients was 61 years (range, 17 to 89 years); 79 were men and 70 women. At the time of the acute thrombotic episode, thrombi involved the popliteal vein in 13 patients, the popliteal and the superficial femoral veins in 62, the popliteal and both the superficial and the common femoral veins in 12, the femoral and the iliac veins in 12, and all the proximal venous system in the remaining 50 patients. Thus, the popliteal vein was rescanned in 137 patients and the common femoral vein in 74.
Twenty-four patients were investigated 3 to 6 months after the acute thrombotic episode, 40 after 6 to 12 months, 48 after 12 to 24 months, and 37 after 24 to 36 months. The C-US test had normalized in 5 patients of the first group (20.8%; 95% CI, 7.1% to 42.1%), in liteal veins, is shown in Fig 1. No difference in the frequency and timing of normalization was recorded between the common femoral and popliteal veins (P=.22). C-US test normalization in both venous segments occurred in 30% of patients within 1 year. In no patients with normalized C-US results did the test revert to abnormal during follow-up in the absence of symptomatic DVT recurrence. Fig 2 shows the evolution of the residual vein diameter during vein compression, separately for the common femoral and the popliteal veins. A statistically significant reduction (P<.0001) was recorded in both the popliteal and the common femoral veins throughout the entire study period. However, a major reduction of thrombus mass (62% in the common femoral and 50% in the popliteal veins) occurred within the first 3 months of follow-up.
Interobserver agreement. In the series of 100 consecutive ultrasound assessments in which the evaluation of a second independent observer was obtained, the test interpretation differed between the two operators in two cases (K=O.95; 95% CI, 0.88 to 1.00).
Recurrence of DVT. During the study period, 29 patients developed symptoms suggestive of DVT recurrence. In 5, the clinical indications arose within 1 to 3 months of follow-up, in 11 within 3 to 6 months, in 6 within 6 to 12 months, and in the remaining 7 In 11 patients (38%), phlebography showed a recurrent DVT: among them, 1 isolated distal and 10 proximal and distal thrombosis (involving the popliteal and the superficial femoral veins in 3, the iliofemoral tract in 2, and all the proximal venous system in the remaining 5) were recorded. In the remaining 18 patients, phlebography (alone or combined with radiofibrinogen uptake test) could exclude the development of recurrence of DVT. Of the 29 patients with suspected DVT recurrence, C-US had already normalized in both the popliteal and the common femoral veins in 6 (20.7%; 95% CI, 8.0% to 39.7%) and reverted to abnormal in the 3 patients with proximal DVT recurrence (sensitivity and specificity, 100%).
In all 10 patients with confirmed proximal recurrence of DVT, the ultrasound test demonstrated noncompressibility of a previously normal(ized) popliteal or common femoral vein and/or an increased vein diameter (>2 mm) compared with the previous assessment (sensitivity of the combined C-US and thrombus thickness methods to proximal recurrence of DVT, 100%; 95% CI, 69% to 100%). In the patient with isolated calf recurrence of DVT, the test was unchanged compared with the previous assessment (sensitivity to all DVT recurrences, 91%; 95% CI, 59% to 100%). In all 18 patients without recurrence of DVT, the ultrasound test demonstrated an unchanged or improved residual vein diameter compared with the previous ultrasound assessment (specificity, 100%; 95% CI, 81% to 100%).
In the 7 patients in whom the thrombus thickness determination confirmed the diagnosis of recurrent proximal-vein thrombosis, the vein diameter was found to be enlarged by 2 there is general agreement on the need to perform objective tests to make management decisions for patients with recurrent leg symptoms. Contrast venography, the gold standard for the diagnosis of acute venous thrombi, presents serious limitations in this context, because it is difficult to visualize a constant intraluminal filling defect (the diagnostic hallmark) in vessels that have been obliterated by the previous thrombotic process.15,16 Serial impedance plethysmography alone14 and the combination of radiofibrinogen leg scanning with impedance plethysmographyl5,16 are the only reliable alternative strategies. However, the latter approach is rather complicated and thus is applicable only in academic centers. Serial plethysmography is available only in a limited number of hospitals and can be applied only in patients with an already normalized test result. Moreover, its accuracy has recently been questioned even in patients with the first clinical indications of DVT.17, 18 The implication of the lack of a practical diagnostic approach is that up to 70% of patients with nonthrombotic disorders are incorrectly labeled as affected by a recurrent episode of DVT and thus receive an unnecessary new course of long-term (often lifelong) anticoagulant therapy. '6 Real-time B-mode ultrasonography, applying the single criterion of full compressibility of the common femoral and the popliteal vein, has been shown to be a highly accurate, objective, and reproducible method for the detection of acute proximal-vein thrombosis in symptomatic patients.'-5 To be useful in patients with suspected DVT recurrence, however, the test should revert to normal in a substantial proportion of patients before symptoms recur. Available information in small samples of patients suggests that up to 50% of previously abnormal C-US tests do not normalize during long-term follow-up.6-9 Both our cross-sectional survey and our prospective investigation in large series of patients, assessing frequency and timing of normalization of this test in patients with proximal DVT, confirm these data. The C-US test, indeed, normalized in only 30% of patients with proximal-vein thrombosis within 1 year, when the expected incidence of DVT recurrence is notoriously higher.14-'6 Moreover, in contrast to data recently reported,9 no difference in the normalization rate between the common femoral vein and the popliteal vein was recorded. As expected, only six (21%) of the 29 patients presenting with new clinical symptoms had an already normalized C-US test and therefore could have been managed correctly with the C-US method alone. This rate is far lower than that reported for the serial IPG approach (about 80%).14 Consequently, repeated C-US testing using the single qualitative criterion of presence or absence of full compressibility is of small clinical utility for the diagnostic management of patients with recurrent DVT. 9 Two recent ultrasound studies indicated that in patients with an acute proximal-vein thrombosis, the thrombus mass decreases progressively in the first months after the initial episode.7,10 Our study was designed to verify whether the precise quantification of thrombus regression could help in recognizing patients with new thrombotic episodes. Previous experiences in large series of patients with recurrent proximal DVT, diagnosed with repeated phlebography,1""2 suggested that the apposition of fresh thrombotic material to the preexisting clot follows the anatomic distribution pattern observed in the first episode,13 involving the common femoral vein, the popliteal vein, or both. Therefore, we assumed that in the presence of a recurrent thrombotic episode, the residual thrombus mass enlarged and that the enlargement would be measurable by application of the ultrasound procedure to the common femoral and the popliteal veins only.
Our results support this hypothesis. By measuring the residual vein diameter at scheduled times, we were able to record in all patients a gradual decrease of thrombus mass in both the common femoral and the popliteal veins. Interestingly, in most patients we observed a substantial thrombus reduction (>50%) in the first 3 months. Finally, in no patient was an enlargement of thrombus mass recorded during follow-up in the absence of symptomatic recurrences.
In all patients with proximal DVT recurrence, as demonstrated by phlebography, ultrasound showed a noncompressibility of a previously normal(ized) popliteal or common femoral vein and/or an increased vein diameter (22 mm) compared with the last assessment. In all patients in whom venography (alone or combined with leg scanning) could exclude a new proximal thrombotic process, the residual vein diameter was unchanged or improved. As a result, the addition of the thrombus thickness determination to the C-US method allowed a correct diagnosis in 100% of patients we investigated during the study period because of new symptoms.
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